CIBC World Market
ABCL icon

CIBC World Market’s AbCellera Biologics ABCL Stock Holding History

CIBC World Market’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135K Sell
17,246
-550
-3% -$2.69K ﹤0.01% 1501
2026
Q1 		$62.1K Sell
17,796
-2,910
-14% -$10.5K ﹤0.01% 1441
2025
Q4 		$70.8K Buy
20,706
+4,341
+27% +$19.4K ﹤0.01% 1416
2025
Q3 		$82.3K Sell
16,365
-8,700
-35% -$38.3K ﹤0.01% 1382
2025
Q2 		$86K Buy
25,065
+1,500
+6% +$3.73K ﹤0.01% 1322
2025
Q1 		$52.5K Buy
23,565
+6,700
+40% +$19.2K ﹤0.01% 1326
2024
Q4 		$49K Sell
16,865
-800
-5% -$2.23K ﹤0.01% 1336
2024
Q3 		$46K Sell
17,665
-500
-3% -$1.39K ﹤0.01% 1278
2024
Q2 		$54K Buy
18,165
+2,940
+19% +$11.1K ﹤0.01% 1236
2024
Q1 		$69K Buy
15,225
+850
+6% +$4.34K ﹤0.01% 1259
2023
Q4 		$82K Sell
14,375
-12,430
-46% -$57.6K ﹤0.01% 1208
2023
Q3 		$123K Sell
26,805
-10,300
-28% -$62.7K ﹤0.01% 1178
2023
Q2 		$240K Sell
37,105
-1,900
-5% -$13K ﹤0.01% 1097
2023
Q1 		$294K Buy
39,005
+5,330
+16% +$48.4K ﹤0.01% 1051
2022
Q4 		$341K Buy
33,675
+1,500
+5% +$17.3K ﹤0.01% 1020
2022
Q3 		$318K Buy
32,175
+5,700
+22% +$62.5K ﹤0.01% 998
2022
Q2 		$282K Sell
26,475
-2,425
-8% -$20.5K ﹤0.01% 1041
2022
Q1 		$282K Sell
28,900
-11,053
-28% -$105K ﹤0.01% 1104
2021
Q4 		$571K Sell
39,953
-37,287
-48% -$566K ﹤0.01% 938
2021
Q3 		$1.55M Buy
77,240
+9,097
+13% +$161K 0.01% 667
2021
Q2 		$1.5M Buy
68,143
+10,918
+19% +$301K ﹤0.01% 683
2021
Q1 		$1.94M Buy
+57,225
New +$2.28M 0.01% 596

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

CIBC World Market's ABCL Position: Q2 2026 in Review

CIBC World Market reduced its AbCellera Biologics (ABCL) stake by 3.1% in Q2 2026, selling an estimated $2.69K and leaving 17,246 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

CIBC World Market first reported a position in ABCL in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.94M in Q1 2021. 150 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • CIBC World Market held 17,246 shares of AbCellera Biologics worth $135K as of Q2 2026.
  • CIBC World Market sold 550 AbCellera Biologics shares in Q2 2026, an estimated $2.69K.
  • AbCellera Biologics made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1501 holding.
  • CIBC World Market first reported a position in AbCellera Biologics in Q1 2021 and has held it in 22 quarters since.
  • CIBC World Market's AbCellera Biologics position peaked at $1.94M in Q1 2021.
  • 150 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.